HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡ ±âÀÚȸ¿ø½Åû
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2024³â03¿ù29ÀÏfri
±â»çÃÖÁ¾ÆíÁýÀÏ: 2024-03-29 19:14:17
´º½ºÈ¨ > ¾à»ç
2017³â11¿ù17ÀÏ 09½Ã54ºÐ
±ÛÀÚÅ©±â ±â»ç³»¿ë À̸ÞÀϺ¸³»±â ´º½ºÇÁ¸°Æ®Çϱ⠴º½º½ºÅ©·¦Çϱâ
JWÁß¿ÜÁ¦¾à ¡®¸®¹Ù·Î¡¯, µ¿¾çÀÎ °ü»óµ¿¸ÆÁúȯ ȯÀÚ¿¡ 'È¿°úÀû'
'µ¿¾çÀο¡¼­µµ °í¿ë·® statinÀ» »ç¿ëÇÒ ¼ö ÀÖ´Ù´Â »õ·Î¿î ±Ù°Å Á¦½Ã'

Å°¹«¶ó ŸÄɽà ±³¼ö ¿¬±¸ÆÀ, ‘REAL-CAD’ ¿¬±¸°á°ú ¹ßÇ¥

[º¸°ÇŸÀÓÁî] °íÁöÇ÷Áõ Ä¡·áÁ¦ ‘¸®¹Ù·Î’°¡ °ü»óµ¿¸ÆÁúȯÀ» ¾Î°í ÀÖ´Â µ¿¾çÀΠȯÀÚ¸¦ ´ë»óÀ¸·Î ÁÖ¿ä ½ÉÇ÷°ü Áúȯ ¹ß»ý·üÀ» °¨¼Ò½ÃŲ´Ù´Â °á°ú°¡ ¼¼°è ÇÐȸ¿¡¼­ ¼Ò°³µÆ´Ù.

JWÁß¿ÜÁ¦¾à(´ëÇ¥ ÇѼº±Ç·½Å¿µ¼·)Àº Áö³­ 11ÀÏ(ÇöÁö½Ã°£)ºÎÅÍ 5ÀÏ°£ ¹Ì±¹ ¾Ö³ÊÇÏÀÓ¿¡¼­ ¿­¸° 2017 ¹Ì±¹½ÉÀåÇÐȸ(AHA: American Heart Association)ÀÇ ‘Late Breaking Science in Prevention session’¿¡¼­ ¾Æ½Ã¾Æ °ü»óµ¿¸ÆÁúȯ ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ °í¿ë·®°ú Ç¥ÁØ¿ë·®ÀÇ ½ºÅ¸Æ¾(stain) ºñ±³ ¿¬±¸°á°úÀÎ ‘REAL-CAD’°¡ ¼Ò°³µÆ´Ù°í 17ÀÏ ¹àÇû´Ù.

À̹ø ¹ßÇ¥ ³»¿ëÀº Å°¹«¶ó ŸÄɽà ±³¼ö(ÀϺ» ±³Åä ´ëÇÐ ½ÉÇ÷°ü ÀÇÇаú) ¿¬±¸ÆÀÀÌ 2010³â 1¿ùºÎÅÍ 2013³â 3¿ù±îÁö °ü»óµ¿¸Æ ÇùÂøÀÌ 50% ÀÌ»óÀÎ ÀϺ»ÀΠȯÀÚ 1¸¸ 4774¸íÀ» ´ë»óÀ¸·Î ¸®¹Ù·Î(¼ººÐ¸í : ÇÇŸ¹Ù½ºÅ¸Æ¾) 1mg°ú 4mgÀ» Åõ¿©ÇØ ºñ±³ÇÑ ÀÓ»ó°á°ú´Ù.

¾Æ½Ã¾Æ °ü»óµ¿¸ÆÁúȯ ȯÀÚ¸¦ ´ë»óÀ¸·Î ´ë±Ô¸ð, ¹«ÀÛÀ§ ¹èÁ¤ °í¿ë·® ½ºÅ¸Æ¾ÀÇ À¯È¿¼º°ú ¾ÈÀü¼ºÀ» Æò°¡¹ÞÀº °ÍÀº À̹øÀÌ Ã³À½ÀÌ´Ù.

¿¬±¸ÁøÀº ÀÏÂ÷Æò°¡º¯¼ö(primary end-point)·Î¼­ ½ÉÇ÷°üÁúȯ °ü·Ã »ç¸Á(CV death), ½É±Ù°æ»öÁõ(MI), ÇãÇ÷¼º ³úÁ¹Áß(ischemic stroke), ºÒ¾ÈÁ¤Çü Çù½ÉÁõ(unstable angina) µîÀÇ ¹ß»ý·üÀ» Æò°¡Çß´Ù. ±× °á°ú ‘¸®¹Ù·Î 4mg’°¡ ‘¸®¹Ù·Î 1mg’ 5.4% º¸´Ù 19% °¨¼Ò½ÃŲ 4.3%¸¦ ³ªÅ¸³Â´Ù. (HR 0.81, 95% CI 0.69-0.95, cox P=0.01)

ÀÏÂ÷Æò°¡º¯¼ö¿Í °ü»óµ¿¸ÆÇ÷°üÀç»ý¼ú(coronary revascularization)¸¦ Æ÷ÇÔ½ÃŲ ÀÌÂ÷Æò°¡º¯¼ö(secondary end-point)¿¡¼­µµ ‘¸®¹Ù·Î 4mg’ ±×·ì 7.9%, ‘¸®¹Ù·Î 1mg’ ±×·ì 9.7% µîÀ¸·Î ‘¸®¹Ù·Î 4mg’°¡ ÁÖ¿ä ½ÉÇ÷°ü Áúȯ ¹ß»ý À§ÇèÀ» 17% °¨¼Ò½ÃÄ×´Ù. (HR 0.83, 95% CI 0.73-0.93, cox P=0.002)

¾ÈÀü¼º º¸°í¿¡¼­ Ⱦ¹®±Ù À¶ÇØÁõ (0% vs. 0%, p=0.62), »õ·Î¿î ´ç´¢º´ ¹ßº´ (4.3% vs. 4.5% p=0.76), °£¼öÄ¡ »ó½Â (2.7% vs. 2.9%, p=0.46), CK »ó½Â (0.6% vs. 0.7%, p=0.83)·Î¼­ ¾ç±º°£ÀÇ Â÷À̸¦ º¸ÀÌÁö ¾Ê¾Ò´Ù.

¹ßÇ¥ÀÚ·Î ³ª¼± Å°¹«¶ó ŸÄɽà ±³¼ö´Â “À̹ø ¿¬±¸¸¦ ÅëÇØ ¾Æ½Ã¾Æ °ü»óµ¿¸ÆÁúȯ ȯÀÚ¿¡¼­µµ ±âÁ¸ÀÇ ¹Ì±¹°ú À¯·´ ¿¬±¸°á°ú¿Í °°ÀÌ °í¿ë·® ½ºÅ¸Æ¾ÀÌ Àú¿ë·®º¸´Ù ÀÓ»ó °á°ú¸¦ È£Àü½ÃÅ°´Â µ¥ º¸´Ù È¿°úÀûÀ̶ó´Â Á¡À» È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù”¸ç “µ¿¾çÀÎÀ» ´ë»óÀ¸·Î ÁÖ¿ä ½ÉÇ÷°üÁúȯÀÇ À§ÇèÀ» ÁÙÀ̴µ¥ °í¿ë·® ½ºÅ¸Æ¾À» »ç¿ëÇÒ ¼ö ÀÖ´Ù´Â »õ·Î¿î ±Ù°Å¸¦ Á¦½ÃÇß´Ù´Â Á¡¿¡¼­ ±× Àǹ̰¡ Å©´Ù”°í ¸»Çß´Ù.

¸®¹Ù·Î´Â Áö³­ 3¿ù ¿µ±¹À» ½ÃÀÛÀ¸·Î 8°³±¹¿¡¼­ ‘´ç´¢º´¹ß»ý À§Çè¡ÈÄ ¾øÀ½’À» °øÀιÞÀº Á¦Ç°ÀÌ´Ù. Áö³­ 8¿ù Çѱ¹ÀÎ ±Þ¼º½É±Ù°æ»ö ȯÀÚ ¾à 1,100¸íÀ» ´ë»óÀ¸·Î ÇÑ ‘LAMIS¥±’ ÀÓ»ó½ÃÇè °á°ú ¹ßÇ¥¿¡¼± ¸®¹Ù·Î°¡ ÁÖ¿ä ½ÉÀå»ç°Ç ¹ß»ý·üÀ» ³·Ãß°í Ç÷´çÀ» °³¼±ÇÏ´Â È¿°ú¸¦ ³ªÅ¸³Â´Ù´Â »ç½ÇÀÌ °ø°³µÆ´Ù.

 

°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù
´º½º½ºÅ©·¦Çϱâ
¹Ú¼÷Èñ (bktimes@naver.com) ±âÀÚ 
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
¾à»ç¼½¼Ç ¸ñ·ÏÀ¸·Î
¼­¿ï´ëº´¿ø, Å¥¶óÄÍ°ú MOU ...
´õÄÉÀÌÈ£ÅÚ¼­¿ï, 'ÀÚ¿¬¹ä»ó...
Ú¸ ±¹¹Î¾à»ç '¼öÁöÄÚÇî' Åë...
¾ÏÁ¨ ÀÚȸ»ç µðÄÚµå Á¦³×ƽ...
°æÈñ´ëÇб³ÀÇ·á¿ø, ¸ÞŸ¹ö...
´ÙÀ½±â»ç : ºÐ´ç¼­¿ï´ëº´¿ø ÀÓ¼ö ±³¼ö, ¹Ì±¹³»ºÐºñÇÐȸ ÀâÁö ÆíÁýÀ§¿ø À§ÃË (2017-11-22 10:07:51)
ÀÌÀü±â»ç : µ¿±¹Á¦¾à, Ƽ½´Å¸ÀÔ ¿©¼ºÃ»°áÁ¦ ¡®Ä¥¸®(Chilly) Æ÷ÄÏ Æ¼½´¡¯ Ãâ½Ã (2017-09-25 15:20:06)
º´¿ø°è, "°è...
º´¿ø°è, "°è¹¦³â...
Á¦¾à¡¤°Ç½Ä 12°³...
°Çº¸°ø´Ü, ¼Ò¼Ó±â°ü '¼­¿ï¿ä¾ç...
¼ºÀåÇÏ°íÇ ´ç½Å, "Áö±Ý ´ë¿õ,...
º¸·ÉÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷Á÷ ...
°Çº¸°ø´Ü, ¿ÃÇØ '°³¹æÇü Á÷°ú ...
°Çº¸°ø´Ü, '¿Ã Á¦3Â÷ °³¹æÇü ...
³í¹®) Inhalation Delivery of Interferon-¥ë-Loaded....  
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶